This application relates to the field of
veterinary drug technology, and discloses a
transdermal absorption-enhancing ointment and its preparation process. The ointment components include
white petrolatum,
anhydrous lanolin, caprylic /
capric triglycerides, hydrophobic
fumed silica, and a highly fluid active
permeation-enhancing phase. The
permeation-enhancing phase contains active drugs and
soybean lecithin, which self-assemble to form an inverse
micelle aggregate.
Soybean lecithin cross-links with the
silanol groups on the surface of silica to form an intermolecular
hydrogen bond network, constructing a sterically hindered framework within a continuous
lipid matrix to prevent the polar
drug-loaded phase from permeating and separating upon heating. Simultaneously, the inverse
micelle structure effectively improves the
transdermal absorption rate of the
drug. The preparation process controls the lipid
crystallization kinetics through
slow cooling under negative pressure and micro-shear dynamic
rheology. This invention solves the problems of easy
precipitation upon heating, low transdermal efficiency, and poor rheological properties in traditional ointments, resulting in a product with a stable
physical structure and good pseudoplastic texture.